Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized trial of nalmefene for alcohol dependence in Japan
jRCT2080222752Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nalmefene in alcohol dependence (3 arms), sponsored by Otsuka Pharmaceutical Co., Ltd. Started Feb 2015; status: completed.
02
Drugs
nalmefene
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on jRCT2080222752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222752.